[Prognosis factors in stomach carcinoma].
Sendler
A
A
Chirurgische Klinik und Poliklinik, Technischen Universität München. sendler@nt.chir.med.tu-muenchen.de
Nekarda
H
H
Böttcher
K
K
Fink
U
U
Siewert
J R
JR
D000230:Adenocarcinoma / Q000401:mortality* / Q000473:pathology / Q000556:secondary / Q000628:therapy; D014408:Biomarkers, Tumor / Q000032:analysis; D001853:Bone Marrow / Q000737:chemistry / Q000473:pathology; D005858:Germany / Q000453:epidemiology; D006801:Humans; D007564:Japan / Q000453:epidemiology; D007633:Keratins / Q000032:analysis; D008207:Lymphatic Metastasis; D009367:Neoplasm Staging; D011379:Prognosis; D013274:Stomach Neoplasms / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D015996:Survival Rate; D014481:United States / Q000453:epidemiology
D014408:Biomarkers, Tumor; D007633:Keratins